| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ayala Pharmaceuticals, Inc. (ADXS) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ADXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2016 | O'Connor Daniel | Chief Executive Officer | Sell | 8,240 | $8.32 | $68,556.80 | -2.7% | |
| Oct 25, 2016 | Mayes, Gregory T. | Chief Business Officer | Sell | 19,162 | $8.23 | $157,703.26 | -15.7% | |
| Aug 9, 2016 | Berman Richard J87 | Director | Sell | 33,761 | $15.42 | $520,754.87 | -22.4% | |
| Aug 9, 2016 | Sidransky David | Director | Sell | 22,808 | $15.01 | $342,348.08 | -11.7% | |
| May 13, 2016 | McKearn Thomas J | Director | Sell | 4,100 | $7.45 | $30,545.00 | -4.8% | |
| May 2, 2016 | O'Connor Daniel | Chief Executive Officer | Sell | 8,237 | $7.51 | $61,859.87 | -2.6% | |
| May 2, 2016 | Petit Robert | Chief Scientific Officer | Sell | 2,785 | $7.51 | $20,915.35 | -2.2% | |
| Mar 31, 2016 | Petit Robert | Chief Scientific Officer | Sell | 3,325 | $9.13 | $30,357.25 | -2.5% | |
| Mar 16, 2016 | McKearn Thomas J | Director | Sell | 14,000 | $8.25 | $115,500.00 | -14.0% | |
| Feb 24, 2016 | Bonstein Sara | Chief Financial Officer | Sell | 15,037 | $5.58 | $83,906.46 | -15.8% |